BiotechTube
Home/PRM Pharma/Deborah Maroko, MD
DM

Deborah Maroko, MD

Head, Medical Affairs

PRM Pharma

Therapeutic Areas

CardiovascularRare DiseaseMetabolic

PRM Pharma Pipeline

DrugIndicationPhase
HemiClor (hydrochlorothiazide 6.25 mg)Hypertension in adultsApproved

Leadership Team at PRM Pharma

JT
Joseph T. McDevitt
President and CEO
MS
Melvin Sharoky, MD
Head, Corporate and Scientific Affairs
PR
Peter R. Kowey, MD
Head, Cardiovascular Products
View full PRM Pharma profile